Areas of Practice
- Antimicrobials (FIFRA) & Biocides (BPD & BPR)
- Chemical Regulation
- Chinese Chemical Regulation
- Drugs and Medicinal Products
- Enforcement Support & Legal Advocacy
- Medical Devices
- Toxic Substances Control Act (TSCA)
- Environment & Life Sciences
- Life Sciences, Food & Health
- Food Contact & Food Regulation
- University of Memphis in Chemistry, B.S., 1986
- University of Florida in Chemistry, Ph.D., 1990
Dr. Mitchell Cheeseman
Washington DC 20036
TEL: +1 202 429 6473
FAX: +1 202 429 3902
Dr. Mitchell Cheeseman is a managing director at Steptoe, where he is a member of the Regulatory & Industry Affairs Department. He has 20 years of experience as an official at the US Food and Drug Administration. Dr. Cheeseman primarily assists manufacturers achieve and document regulatory compliance for products regulated by FDA and EPA. He also provides the same assistance to clients marketing such products in the European Union (EU), China, South America and Asia. He has experience assisting such manufacturers with issues regarding both premarket approval and compliance issues as well as postmarket issues including compliance with the Food Safety Modernization Act (FSMA) and implementing regulations. He provides strategic advice in support of product research and development to optimize return on investment with respect to regulatory requirements and market entry.
Dr. Cheeseman left FDA in November 2011 after serving more than five years as a member of the leadership of the Center for Food Safety and Applied Nutrition. In this capacity, he led FDA’s food ingredient and packaging programs including primary responsibility for the regulation of direct food additives and food contact substances, color additives, Generally Recognized as Safe (GRAS) food ingredients, and bioengineered food. Dr. Cheeseman served as the primary contact for advice on regulatory science and policy to all other FDA product centers in areas where FDA’s Office of Food Additive Safety had primary or overlapping regulatory responsibility and where FDA/OFAS had specialized expertise in regulatory science. As such, he dealt closely with scientists and policymakers in FDA’s medical device and drug programs as well as in the Center for Veterinary Medicine and the Center for Tobacco Products. During his tenure he provided guidance and negotiated policy on significant issues including the regulation of colors in medical devices, the safety of plastic materials used in the manufacturing and packaging of medical devices and drugs, regulatory policy on nanotechnology and the safety of certain substances (e.g. Bisphenol A and phthalates), which cut across multiple product areas.
Dr. Cheeseman has diverse experience dealing with policy issues regarding chemical risk assessment and regulation including experience navigating cross-jurisdictional issues involving regulation by FDA, USDA, CPSC, TTB, and EPA. As the acting director and deputy director of FDA’s Office of Food Additive Safety, he led enforcement activities on a wide range of areas. He has substantial experience working with a wide range of food and food packaging companies as well senior governmental officials in US and foreign regulatory agencies, members of the press, and Congressional staff.
Dr. Cheeseman has been an invited speaker and participant at many international meetings, workshops, and working groups regarding the use of probabilistic risk assessment in the regulation of chemicals and the Threshold of Toxicological Concern (TTC). His work regarding structural alerts for carcinogenicity is the primary basis for the cancer thresholds in the existing TTC approach applied to the regulation of food flavors by the FAO/WHO Joint Expert Committee on Food Additives and by FDA to the regulation of food contact materials. In addition, his work is the basis for the current regulatory standards for genotoxic impurities in pharmaceuticals which have been adopted by the European Medical Products Agency (EMEA) and the US Food and Drug Administration Center for Drug Evaluation and Research. He has been an invited expert for consultations on regulatory science sponsored by such organizations as the United Nations Food and Agricultural Organization, the European Food Safety Authority, and the International Life Sciences Institute as well as serving as an ad hoc member of the Science Advisory Panel for the Environmental Protection Agency Office of Pesticide Programs and Toxics.
In addition, he has substantial experience working on FDA’s development and implementation of legislation including the Food Quality Protection Act, the FDA Modernization Act, the Public Health Security and Bioterrorism Preparedness and Response Act, the Antimicrobials Technical Corrections Act, and the FDA Amendments Act.
Select News & Events
- Food Contact Compliance Training Course, September 22, 2016, A Steptoe-sponsored event
- Food Chemical News Features Mitchell Cheeseman in Q&A on FDA GRAS Rule
- Establishing a FSVP for Imported Food Contact Substances, June 9, 2016, A Steptoe-sponsored event
- Food Contact Compliance Training Course, April 20, 2016, A Steptoe-sponsored event
- “EU Biocidal Products Regulation,” Biocides USA, April 11, 2016
- "BPA: The Current State of Play,” American Beverage Association, February 17, 2016
- Recent Developments in EU and US Food Law, November 12, 2015, A Steptoe-sponsored event
- Food Chemical News Quotes Mitch Cheeseman on FEMA’s GRAS Program
- Law360 Quotes Mitch Cheeseman on FDA Safe-Ingredient List
- Law360 Quotes Mitch Cheeseman on Trans Fat Proposal
- Cheeseman, Simmons Preview Food Additives in 2013 on ‘Knife & Fork Show’
- Mitchell Cheeseman, Ralph Simmons Discuss Caffeine on ‘Knife & Fork Show’
- Current IFT representative to the Codex Committee on Food Additives